COVID-19

ISARIC has been committed to provide a wide breadth of COVID-19 clinical research resources since the beginning of the outbreak. These resources are fully adaptable and completely free to use

The tools below aim to cover a range of tiers, suitable for different needs:

  • Data collection only
  • Contributing clinical data
  • Research protocols
  • Guidance to start your study
  • ISARIC’s affiliated studies

Evidence & Reports

Tile subhead - Publications and Clinical data reports stemmed from the ISARIC COVID-19 clinical data platform.

COVID-19 CRF

Tile subhead - Collection of standardised clinical data.

Optional CRF Modules

Tile subhead - Modules to be used in addition to the Core or RAPID COVID-19 CRFs.

MIS-C in children and adolescents

Tile subhead - Stand alone CRF for children and adolescents.

Contributing data to the COVID-19 platform

Tile subhead - Secure data capture system that standardises global data on COVID-19.

Accessing COVID-19 clinical data

Tile subhead - Access ISARIC's data to generate and disseminate evidence.

ISARIC Partner Analysis

Tile subhead - Data analysis frequently asked questions.

Approved uses of platform data

Tile subhead - Current data research analyses.

Clinical data contributors

Tile subhead - Sites currently contributing to the clinical data platform.

Clinical Characterisation Protocol

Tile subhead - ISARIC/WHO protocol for standardised clinical data collection.

COVID-19 Long term protocol & survey

Tile subhead - Follow-up clinical data collection

COVID-19 CCP Global Toolkit

Tile subhead - Guidance on the Global Clinical Characterisation Protocol.

COVID-19 Rapid Evidence Reviews Group (CORRE)

Tile subhead - High quality rapid evidence synthesis for use in COVID-19 research.

Associated clinical studies in COVID-19

Tile subhead - Clinical data collection with the aims of building a research or study

Publication library

Visit this section to find ISARIC’s articles, studies and more.

Latest news

Women under 50 had worse long-term outcomes after hospitalisation with COVID-19

Women under 50 had worse long-term outcomes after hospitalisation with COVID-19

Women under 50 and people who experienced severe disease had worse long-term outcomes following hospitalisation with COVID-19.

Key inflammatory markers identified in COVID-19

Key inflammatory markers identified in COVID-19

ISARIC, supported by the UK Coronavirus Immunology Consortium (UK-CIC), has identified new biomarkers of inflammation that both indicate the severity of COVID-19 and distinguish it from severe influenza.

Long COVID: tackling a multifaceted condition requires a multi- disciplinary approach

Long COVID: tackling a multifaceted condition requires a multi- disciplinary approach

The Lancet Infectious Diseases  published the GloPID-R and ISARIC Long COVID Forum Working Group’ letter, describing the content and discussions of the Long COVID Forum which took place on 9-10 December 2020.